B-Lymphocyte Antigen CD19 (CD19) Antibody (Biotin)

Este producto es parte de CD19 - CD19 molecule
Product Graph
78€ (25 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
B-Lymphocyte Antigen CD19 (CD19) Antibody (Biotin)
category
Primary Antibodies
provider
Abbexa
reference
abx228003
tested applications
FCM

Description

CD19 Antibody (Biotin) is a Mouse Monoclonal Antibody against CD19.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
B-Lymphocyte Antigen CD19 (CD19)
Host
Rat
Reactivity
Mouse
Clonality
Monoclonal
Conjugation
Biotin
Isotype
IgG2a
Size 1
25 µg
Size 2
100 µg
Tested Applications
FCM
Buffer
PBS with 0.05% Proclin300, 1% BSA.
Availability
Shipped within 5-15 working days.
Storage
Aliquot and store at 2°C to 8°C upon receipt. Avoid exposure to light. Do not freeze.
Dry Ice
No
UniProt ID
P25918
Gene ID
12478
Alias
B4,CVID3,B-lymphocyte antigen CD19,B-lymphocyte surface antigen B4,Differentiation antigen CD19,T-cell surface antigen Leu-12
Background
Antibody anti-CD19
Status
RUO

Descripción

CD19 is a transmembrane glycoprotein primarily expressed on B cells, a subset of white blood cells responsible for producing antibodies and mediating humoral immunity. CD19 plays a crucial role in B-cell development, activation, and differentiation, making it a critical marker and regulator in the immune response. It is part of the immunoglobulin superfamily and serves as a coreceptor for the B-cell receptor (BCR), amplifying BCR-mediated signaling, which is essential for proper immune function. CD19 is expressed throughout most stages of B-cell development, from the pro-B cell stage in the bone marrow to mature B cells in peripheral tissues. This widespread expression makes it a reliable marker for identifying B cells in research and clinical settings, and it is often targeted in therapeutic strategies aimed at modulating B-cell function, such as in CAR-T cell therapy for treating B-cell malignancies.

Related Products

EH4869

Human CD19(Cluster of Differentiation 19) ELISA Kit

Ver Producto
EM0689

Mouse CD19(Cluster of differentiation 19) ELISA Kit

Ver Producto
FNab09868

anti- CD19 antibody

Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.

Ver Producto